The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJtc Plc Regulatory News (JTC)

Share Price Information for Jtc Plc (JTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 842.00
Bid: 844.00
Ask: 846.00
Change: 4.00 (0.48%)
Spread: 2.00 (0.237%)
Open: 845.00
High: 847.00
Low: 839.00
Prev. Close: 838.00
JTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Placing

15 Jun 2023 07:00

RNS Number : 7705C
JTC PLC
15 June 2023
 

15 June 2023

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE, DISTRIBUTION OR FORWARDING, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.

FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

For immediate release

JTC PLC

(the "Company" and together with its subsidiaries "JTC" or the "Group")

Results of Placing

JTC, the global provider of fund, corporate and private client services, is pleased to announce the successful completion of the placing announced on 14 June 2023 (the "Placing").

A total of 8,857,143 Placing Shares have been placed by Numis Securities Limited ("Numis") and Joh. Berenberg, Gossler & Co. KG ("Berenberg") at a price of 700 pence per share (the "Placing Price"), raising gross proceeds of £62.0 million for the Company. The Placing Price represents a discount of 3.2% to the closing price on 14 June 2023 (being the latest practicable time prior to the announcement of the Placing).

Applications have been made for the Placing Shares to be admitted to the premium listing segment of the Official List of the Financial Conduct Authority ("FCA") and to trading on the main market for listed securities of the London Stock Exchange plc ("LSE") (together, "Admission"). Subject to Admission becoming effective, it is expected that settlement for the Placing Shares and Admission will take place at 8.00 a.m. on 19 June 2023. The Placing is conditional, inter alia, upon Admission becoming effective not later than 8.00 a.m. on 30 June 2023 (or such later date as the Company, Numis and Berenberg may otherwise agree) and upon the Placing Agreement becoming unconditional and not being terminated in accordance with its terms prior to Admission.

The Placing Shares, when issued, will be fully paid and will rank pari passu in all respects with the existing shares, including the right to receive all dividends and other distributions declared, made or paid after the date of issue. The issue and allotment of the Placing Shares is within the existing authorities of the JTC Board of Directors.

Total voting rights

Following Admission of the Placing Shares, the Company will have a total of 157,963,642 shares in issue. With effect from Admission, this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interesting in the Company, under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

Director participation in the Placing

Kate Beauchamp, non-executive director of the Group, participated in the Placing and acquired 14,285 Placing Shares. Following Admission, Kate Beauchamp will hold 14,285 Ordinary Shares, representing 0.01% of the total issued share capital of the Company. 

 

The JTC EBT participated in the Placing and acquired 28,571 Placing Shares. Following Admission, the JTC EBT will hold 2,716,973 shares, representing 1.72% of the total issued share capital of the Company.

 

Nigel Le Quesne, Chief Executive Officer of JTC PLC, said:

"We are delighted that new and existing investors have once again supported our growth ambitions. The net proceeds of the fundraise will support the acquisition of South Dakota Trust Company ("SDTC") which is a significant addition to our US platform and makes JTC the leading independent provider of administration services to the US personal trust sector. SDTC is a high quality business with a very attractive financial profile, uniquely experienced management and provides access to a sticky client base of c.1,700 high net worth and ultra-high net worth clients with a large intermediary network."

 

For further information please contact:

JTC plc

Tel: +44 (0) 1534 700 000

Nigel Le Quesne, Chief Executive Officer

 

Martin Fotheringham, Chief Financial Officer

 

David Vieira, Chief Communications Officer

 

 

 

Numis (Joint Bookrunner and Joint Broker)

Stuart Skinner

Tel: +44 (0) 20 7260 1000

Julian Cater

William Baunton

William Wickham

Tom Burrows Smith

 

Berenberg (Joint Bookrunner and Joint Broker)

Toby Flaux

Ben Wright

James Thompson

Milo Bonser

 

 

Tel: +44 (0) 20 3207 7800

Camarco

 

Geoffrey Pelham-Lane

+44 (0) 7733 124 226

Sam Morris

+44 (0) 7796 827 008

 

The person responsible for releasing this announcement is Miranda Lansdowne, Company Secretary.

JTC PLC LEI: 213800DVUG4KLF2ASK33

Pre-Emption Group Reporting

This Placing is a non-pre-emptive issue of equity securities for cash and accordingly the Company makes the following post transaction report in accordance with the most recently published Pre-Emption Group Statement of Principles (2022).

 

Name of issuer

JTC PLC

Transaction details

Placing of 8,857,143 New Ordinary Shares represents 5.9% of the Company's issued ordinary share capital.

Settlement for the Placing Shares and Admission will take place at 8.00 a.m. on 19 June 2023.

Use of proceeds

The proceeds of the proposed Placing will be used to part-fund the acquisition of TC3 Group Holdings LLC, trading as South Dakota Trust Company for total consideration of up to $270 million (c.£214.1[1] million).

Quantum of proceeds

In aggregate, the Placing raised gross proceeds of £62.0 million.

Discount

The Placing Price of 700 pence represents a discount of 3.2 per cent. to the closing price of 723 pence on 14 June 2023.

Allocations

Soft pre-emption has been adhered to in the allocations process. Management were involved in this allocations process, which has been carried out in compliance with the MiFID II Allocation requirements. Allocations made outside of soft pre-emption were preferentially directed towards existing shareholders in excess of their pro rata, and wall-crossed accounts.

Consultation

The Joint Bookrunners undertook a pre-launch wall-crossing process, including consultation with major shareholders, to the extent reasonably practicable and permitted by law.

Retail investors

Following discussions between the Joint Bookrunners and the Company, it was decided that a retail offer would not be included in the Placing. The Placing structure was chosen to minimise cost, time to completion and complexity whilst the Company executed its acquisition of TC3 Group Holdings LLC as announced on 14 June 2023.

 

 

This Announcement should be read in its entirety. In particular, you should read and understand the information provided in the "Important Notices" section of this Announcement.

Important Notices

No action has been taken by the Company, Berenberg, or Numis or any of their respective affiliates, or any person acting on its or their behalf that would permit an offer of the Placing Shares or possession or distribution of this Announcement or any other offering or publicity material relating to such Placing Shares in any jurisdiction where action for that purpose is required. Persons into whose possession this Announcement comes are required by the Company and the Joint Bookrunners to inform themselves about, and to observe, such restrictions.

 

No prospectus, offering memorandum, offering document or admission document has been or will be made available in connection with the matters contained in this Announcement and no such prospectus is required (in accordance with the Prospectus Regulation (EU) 2017/1129 (the "Prospectus Regulation" or the Prospectus Regulation (2017/1129) as it forms part of UK domestic law by virtue of the European Union Withdrawal Act 2018 the "UK Prospectus Regulation" as applicable)) to be published. Persons needing advice should consult a qualified independent legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE, FORWARDING OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (COLLECTIVELY, THE "UNITED STATES"), AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION. THIS ANNOUNCEMENT HAS NOT BEEN APPROVED BY THE LONDON STOCK EXCHANGE, NOR IS IT INTENDED THAT IT WILL BE SO APPROVED.

 

This Announcement or any part of it does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in the United States, Canada, Australia, the Republic of South Africa, Japan or any other jurisdiction in which the same would be unlawful. No public offering of the Placing Shares is being made in any such jurisdiction.

 

The securities referred to herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any State or other jurisdiction of the United States, and may not be offered, sold or transferred directly or indirectly in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with the securities laws of any State or any other jurisdiction of the United States. Accordingly, the Placing Shares are being offered and sold by the Company only (i) outside the United States in "offshore transactions" (as such terms are defined in Regulation S under the Securities Act ("Regulation S")) pursuant to Regulation S under the Securities Act and otherwise in accordance with applicable laws; and (ii) in the United States to a limited number of "qualified institutional buyers" (as defined in Rule 144A under the Securities Act) . No public offering of securities is being made in the United States.

 

This announcement is for information purposes only and is directed only at persons whose ordinary activities involve them in acquiring, holding, managing and disposing of investments (as principal or agent) for the purposes of their business and who have professional experience in matters relating to investments and are: (a) if in a member state of the European Economic Area (the "EEA"), persons who are qualified investors, within the meaning of Article 2(E) of the Prospectus Regulation ("Qualified Investors"); or (b) if in the United Kingdom, 'Qualified Investors' within the meaning of Article 2(E) Of the UK Prospectus Regulation and who are also: (i) persons who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services And Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), or (ii) high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the order, or (c) other persons to whom it may otherwise be lawfully communicated, and in all cases who are capable of being categorised as a professional client or an eligible counterparty for the purposes of the FCA conduct of business rules, (all such persons referred to in (a), (b) and (c) above together being referred to as "Relevant Persons").

 

Any investment or investment activity to which this Announcement relates is available in the EEA or the United Kingdom only to Relevant Persons and will be engaged in only with Relevant Persons. This Announcement must not be acted on or relied on by persons in the EEA or the United Kingdom who are not Relevant Persons.

 

In Canada, no prospectus has been filed with any securities commission or similar regulatory authority in respect of the Placing Shares. No such securities commission or similar regulatory authority in Canada has reviewed or in any way passed upon the merits of any proposed offering of the Placing Shares and any representation to the contrary is an offence; no prospectus has been lodged with, or registered by, the Australian Securities and Investments Commission or the Japanese Ministry of Finance; the relevant clearances have not been, and will not be, obtained for the South Africa Reserve Bank or any other applicable body in the Republic of South Africa in relation to the Placing Shares and the Placing Shares have not been, nor will they be, registered under or offering in compliance with the securities laws of any state, province or territory of Australia, Canada, the Republic of South Africa or Japan. Accordingly, the Placing Shares may not (unless an exemption under the relevant securities laws is applicable) be offered, sold, resold or delivered, directly or indirectly, in or into Australia, Canada, the Republic of South Africa, or Japan or any other jurisdiction in which such activities would be unlawful.

 

Certain statements contained in this Announcement constitute "forward-looking statements" with respect to the financial condition, results of operations and businesses and plans of the Company and its subsidiaries (the "Group"). Words such as "believes", "anticipates", "estimates", "expects", "intends", "plans", "aims", "potential", "will", "would", "could", "considered", "likely", "estimate" and variations of these words and similar future or conditional expressions, are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon future circumstances that have not occurred. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements and forecasts. As a result, the Group's actual financial condition, results of operations and business and plans may differ materially from the plans, goals and expectations expressed or implied by these forward-looking statements. No representation or warranty is made as to the achievement or reasonableness of, and no reliance should be placed on, such forward-looking statements. No statement in this Announcement is intended to be, nor may it be construed as, a profit forecast or be relied upon as a guide to future performance. The forward-looking statements contained in this Announcement speak only as of the date of this Announcement. The Company, its directors, the Joint Bookrunners, their respective affiliates and any person acting on its or their behalf each expressly disclaim any obligation or undertaking to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, unless required to do so by applicable law or regulation, the Listing Rules, MAR, the Disclosure Guidance and Transparency Rules, the rules of the London Stock Exchange or the FCA.

 

Each of the Joint Bookrunners and their respective affiliates may have engaged in transactions with, and provided various commercial banking, investment banking, financial advisory transactions and services in the ordinary course of their business with the Company and/or its affiliates for which they would have received customary fees and commissions. Each of the Joint Bookrunners and their respective affiliates may provide such services to the Company and/or its affiliates in the future.

 

This Announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by either Joint Bookrunner or by any of its affiliates or any person acting on its or their behalf as to, or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

 

This Announcement does not constitute a recommendation concerning any investor's investment decision with respect to the Placing. Any indication in this Announcement of the price at which ordinary shares have been bought or sold in the past cannot be relied upon as a guide to future performance. The price of shares and any income expected from them may go down as well as up and investors may not get back the full amount invested upon disposal of the shares. Past performance is no guide to future performance. The contents of this Announcement are not to be construed as legal, business, financial or tax advice. Each investor or prospective investor should consult his, her or its own legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.

 

The Placing Shares to be issued or sold pursuant to the Placing will not be admitted to trading on any stock exchange other than the London Stock Exchange.

 

Persons (including, without limitation, nominees and trustees) who have a contractual or other legal obligation to forward a copy of this Announcement should seek appropriate advice before taking any action.

 

Neither the content of the Company's website (or any other website) nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this Announcement.

 

This Announcement has been prepared for the purposes of complying with applicable law and regulation in the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this Announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside the United Kingdom.

 

Numis is authorised and regulated in the United Kingdom by the Financial Conduct Authority and is acting solely for the Company and no-one else in connection with the Placing and will not regard any other person (whether or not a recipient of this Announcement) as a client in relation to the Placing, the contents of this Announcement or any other matters described in this Announcement. Numis will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in connection with the Placing, the contents of this Announcement or any other matters described in this Announcement.

Berenberg, which is authorised and regulated by the German Federal Financial Supervisory Authority (BaFin) and in the United Kingdom is deemed authorised under the Temporary Permissions Regime and is subject to limited regulation by the Financial Conduct Authority, is acting solely for the Company and no-one else in connection with the Placing and will not regard any other person (whether or not a recipient of this Announcement) as a client in relation to the Placing, the contents of this Announcement or any other matters described in this Announcement. Berenberg will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in connection with the Placing, the contents of this Announcement or any other matters described in this Announcement.

Notice to Distributors

 

UK Product Governance Requirements

Solely for the purposes of the product governance requirements contained within the FCA Handbook Product Intervention and Product Governance Sourcebook (the "UK Product Governance Rules"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the UK Product Governance Rules) may otherwise have with respect thereto, the Placing Shares have been subject to a product approval process, which has determined that the Placing Shares are: (i) compatible with an end target market of (a) retail clients, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("EUWA"), (b) investors who meet the criteria of professional clients as defined in Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA and (c) eligible counterparties as defined in the FCA Handbook Conduct of Business Sourcebook ("COBS"); and (ii) eligible for distribution through all distribution channels as are permitted by Directive 2014/65/EU (the "UK Target Market Assessment"). Notwithstanding the UK Target Market Assessment, distributors should note that: the price of the Placing Shares may decline and investors could lose all or part of their investment; the Placing Shares offer no guaranteed income and no capital protection; and an investment in the Placing Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom.

The UK Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Placing. Furthermore, it is noted that, notwithstanding the UK Target Market Assessment, the Joint Bookrunners will only procure investors who meet the criteria of professional clients and eligible counterparties. For the avoidance of doubt, the UK Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of COBS; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Placing Shares. Each distributor is responsible for undertaking its own target market assessment in respect of the Placing Shares and determining appropriate distribution channels.

EU Product Governance Requirements

Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "MiFID II Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the Placing Shares have been subject to a product approval process, which has determined that such securities are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the "EU Target Market Assessment"). Notwithstanding the EU Target Market Assessment, distributors should note that: the price of the Placing Shares may decline and investors could lose all or part of their investment; the Placing Shares offer no guaranteed income and no capital protection; and an investment in the Placing Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom.

The EU Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Placing. Furthermore, it is noted that, notwithstanding the EU Target Market Assessment, the Joint Bookrunners are only procuring investors who meet the criteria of professional clients and eligible counterparties. For the avoidance of doubt, the EU Target Market Assessment does not constitute: (a) an assessment of suitability of appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Placing Shares. Each distributor is responsible for undertaking its own target market assessment in respect of the Placing Shares and determining appropriate distribution channels.

Capitalised terms used but not defined in this Announcement have the meaning given in the Placing Announcement unless otherwise stated.

The information below set out in accordance with the requirement of Market Abuse Regulation (EU) NO. 596/2014, including as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Kate Beauchamp

2.

Reason for the notification

(a)

Position/status

Independent Non-Executive Director

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

JTC PLC

(b)

LEI

213800DVUG4KLF2ASK33

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.01 each

(b)

Identification code of the Financial Instrument

JE00BF4X3P53

(c)

Nature of the transaction

Purchase of shares

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

700 pence

14,285

(e)

Aggregated information

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

15 June 2023

(g)

Place of the transaction

London Stock Exchange

 


[1] GBP:USD exchange rate of 1.2612; Source: Bloomberg (13 June 2023)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROIBZLLFXQLLBBK
Date   Source Headline
24th Apr 20247:00 amRNSPDMR Shareholding
22nd Apr 20243:51 pmRNSHolding(s) in Company
22nd Apr 20247:00 amRNSAcquisition of First Republic Trust Co of Delaware
18th Apr 20247:00 amRNSAnnual Financial Report and Notice of AGM
10th Apr 20247:00 amRNSVesting and Grant of Share Plan Awards
9th Apr 20247:00 amRNSFull year results for year ended 31 December 2023
20th Mar 20245:59 pmRNSHolding(s) in Company
4th Mar 20247:00 amRNSCompletion of Acquisition and Issue of Equity
29th Feb 202410:33 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSPre-close Full Year Trading Update
31st Jan 20247:00 amRNSTotal Voting Rights
12th Jan 20247:00 amRNSPayment of SALI earnout and issue of equity
12th Dec 20234:39 pmRNSTR1: Notification of Major Holdings
7th Dec 20237:00 amRNSHolding(s) in Company
24th Nov 20237:00 amRNSAcquisition of Blackheath Capital Management LLP
22nd Nov 202310:22 amRNSHolding(s) in Company
3rd Nov 20237:05 amRNSHolding(s) in Company
2nd Nov 20237:00 amRNSHolding(s) in Company
25th Sep 20237:00 amRNSDirector's Share Dealing
19th Sep 20237:00 amRNSPDMR's Share Dealing
12th Sep 20237:00 amRNSInterim results for the period ended 30 June 2023
1st Sep 20239:00 amRNSTotal Voting Rights
10th Aug 202310:42 amRNSHolding(s) in Company
9th Aug 20231:57 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSCompletion of SDTC Acquisition and Issue of Equity
25th Jul 20237:00 amRNSInterim Trading Update and Notice of Results
21st Jun 20237:00 amRNSIssue of Equity and Voting Rights
20th Jun 20239:43 amRNSHolding(s) in Company
15th Jun 20237:00 amRNSResults of Placing
14th Jun 20234:36 pmRNSProposed Placing of New Ordinary Shares
14th Jun 20234:35 pmRNSAcquisition of South Dakota Trust Company
9th Jun 20239:43 amRNSHolding(s) in Company
31st May 20237:00 amRNSTotal Voting Rights
24th May 20238:12 amRNSResult of AGM
4th May 20237:00 amRNSIssue of Equity and Voting Rights
21st Apr 20237:00 amRNSAnnual Financial Report and Notice of AGM
12th Apr 20237:00 amRNSVesting and Grant of Performance Share Plan Awards
11th Apr 20237:00 amRNSFull year results for year ended 31 December 2022
7th Mar 20231:57 pmRNSHolding(s) in Company
13th Feb 202312:08 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSPre-close Full Year Trading Update
14th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20222:52 pmRNSFormation of Governance and Risk Committee
1st Nov 20227:00 amRNSCompletion of NYPTC Acquisition
13th Sep 20227:00 amRNSInterim results for the period ended 30 June 2022
26th Aug 20227:00 amRNSProposed Acquisition of NYPTC
27th Jul 20227:00 amRNSEIP Award Vesting
22nd Jul 20227:00 amRNSPre-close Interim Update and Notice of Results
15th Jul 20227:00 amRNSNomination Committee Appointment
8th Jul 202211:43 amRNSDirector's Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.